Patent™ Evening Seminar Brussels_Oct. 2024

Tickets

Patent™ Evening Seminar Brussels_Oct. 2024

Brussels, Belgium

We cordially invite you to this informative Patent™ Evening Seminar with internationally renowned researcher Dr. Roland Glauser, taking place on October 3, 2024, in Brussels (Belgium).

This seminar will focus on peri-implantitis, a chronic inflammatory condition that affects one in five dental implants, according to the EFP (Herrera et al., 2023). Managing this highly prevalent disease is challenging, unpredictable, and associated with significant morbidity. Peri-implantitis is irreversible and cannot be treated with long-term success. Studies show that current therapy options always fail to achieve full re-osseointegration of the initially exposed implant surface. Therefore, our focus must shift towards prevention - using new concepts and technologies.

The Patent™ Dental Implant System represents a breakthrough in this field. Patent™ has been proven in two long-term studies that it can prevent peri-implantitis – the first dental implant in history ever to achieve this.

Prepare to be amazed to learn from Dr. Roland Glauser how the Patent™ Dental Implant System prevents peri-implantitis. The secret lies in its gapless transmucosal design, sealed implant-abutment connection, and mucophilic transmucosal surface, which promotes soft-tissue adhesion so strong, it can prevent the downward migration of plaque - creating an effective defense barrier against bacteria.

Register for the Evening Seminar in Brussels and discover how you too can achieve implant dentistry without peri-implantitis for your patients!

Dr. Roland Glauser

Tickets

Date et heure
jeudi 3 octobre 2024
19:00 23:00 (Europe/Zurich)

Ajouter au calendrier

Lieu

The Crescent

Lenniksebaan 451
1070 Anderlecht
Belgique
--The Crescent--

Obtenez l'itinéraire

Organisateur

Colette Persson

+33 2 32 24 64 98
+41 78 211 20 12
colette.persson@zircon-medical.com
Partager

Découvrez ce que les gens voient et disent à propos de cet événement et rejoignez la conversation.